Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Norway Prior Information Notice 2026-02-14
Germany Open House Drug Discount Agreements For The Active Ingredient Eltrombopag, Atc B02bx05 2026-02-14
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To § 130a Abs.8 Sgb V With The Active Substance Natalizumab Ifk, Medicines 2026-02-14
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Epoetin Alfa 2026-02-14
Italy Preliminary Consultation Of The Preparatory Market For The Invading Of An Open Procedure, Divided Into 3 Lots, For The Supply And Rental Of Systems Necessary For The Laboratory Of Microbiology And Virology Of The Provincial Company For Health Services In 2026-02-14
United Kingdom External Quality Assessment (eqa) Service For The Tests Listed In The Genomic Test Directory 2026-02-14
Germany Completion Of Non -existing Discount Agreements According To § 130 A Para. 8 Sgb V To Biosimilar Active Ingredients From 01.10.2025 2026-02-15
Germany Completion Of Non-exclusive Discount Agreement According To Section 130a (8) Sgb V For The Active Ingredient Fluorouracil (efudix) -vv 86 2026-02-15
Germany Completion Of Non-exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Olanzapine (trs) -vv 86 2026-02-15
Germany Completion Of Non-exclusive Discount Agreement According To Section 130a (8) Sgb V For The Active Ingredient Ciclosporin (ikervis) -vv 86 2026-02-15
Whats app